Literature DB >> 2329569

Synthesis and biological activity of some derivatives of rifamycin P.

B Cavalleri1, M Turconi, G Tamborini, E Occelli, G Cietto, R Pallanza, R Scotti, M Berti, G Romanó, F Parenti.   

Abstract

A series of derivatives of rifamycin P, an antibiotic produced by fermentation of a mutant strain of Nocardia mediterranea or by chemical modification of rifamycin S, have been prepared. The structures of these compounds were determined by 1H NMR, IR, UV, and LC/MS. Their in vitro and in vivo antibacterial activities in comparison with rifampicin and two other rifamycins under investigation were evaluated. The derivatives were more active than rifamycin P against Mycobacterium avium complex and other slowly and rapidly growing nontuberculous mycobacteria which frequently cause systemic infection in patients with AIDS. 2'-(Diethylamino)rifamycin P (P/DEA) appears suitable for further investigation.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2329569     DOI: 10.1021/jm00167a029

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  5 in total

Review 1.  Bacterial challenges and evolving antibacterial drug strategy.

Authors:  B Watt; J G Collee
Journal:  Postgrad Med J       Date:  1992-01       Impact factor: 2.401

2.  Bacillus subtilis tolerance of moderate concentrations of rifampin involves the sigma(B)-dependent general and multiple stress response.

Authors:  Julia Elisabeth Bandow; Heike Brötz; Michael Hecker
Journal:  J Bacteriol       Date:  2002-01       Impact factor: 3.490

3.  In vivo activities of newer rifamycin analogs against Mycobacterium avium infection.

Authors:  S P Klemens; M H Cynamon
Journal:  Antimicrob Agents Chemother       Date:  1991-10       Impact factor: 5.191

4.  Ribosylation by mycobacterial strains as a new mechanism of rifampin inactivation.

Authors:  E R Dabbs; K Yazawa; Y Mikami; M Miyaji; N Morisaki; S Iwasaki; K Furihata
Journal:  Antimicrob Agents Chemother       Date:  1995-04       Impact factor: 5.191

5.  Inactivation of rifampin by Nocardia brasiliensis.

Authors:  K Yazawa; Y Mikami; A Maeda; M Akao; N Morisaki; S Iwasaki
Journal:  Antimicrob Agents Chemother       Date:  1993-06       Impact factor: 5.191

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.